1H-indol-5-yl methanesulfonate | 128810-31-1

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1H-indol-5-yl methanesulfonate
• CAS: 128810-31-1
• 化学式: C₉H₉NO₃S
• 分子量: 211.241
• InChiKey: IAMXTDCFMWTBCK-UHFFFAOYSA-N

物化性质

• 熔点：
  96-98 °C
• 沸点：
  433.8±27.0 °C(Predicted)
• 密度：
  1.437±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  67.5
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  1H-indol-5-yl methanesulfonate 在 溴 、 sodium cyanoborohydride 、 溶剂黄146 作用下， 以 二氯甲烷 为溶剂， 生成 7-bromo-5-(methylsulfonyloxy)indoline
  参考文献：
  名称：

  铃木芳基-芳基交叉偶联反应合成芳芳科生物碱类乌地明和马来酸

  摘要：

  描述了基于芳基硼酸-芳基卤化物交叉偶合方法的甜菜碱生物碱非甾体胺（1）和内酰胺生物碱河马碱（4）的短合成。

  DOI：

  10.1016/0040-4039(90)80006-8
• 作为产物：
  描述：

  indolin-5-yl methanesulfonate 在 新铜试剂 、 氧气 、 palladium diacetate 作用下， 以 氯苯 为溶剂， 以92 %的产率得到1H-indol-5-yl methanesulfonate
  参考文献：
  名称：

  在无醇盐条件下通过钯 (II) 催化需氧脱氢合成 1H-吲哚、喹啉和 6 元芳香族 N-杂环稠合支架

  摘要：

  开发了一种高效的钯 (II) 催化的饱和N-杂环稠合支架的有氧脱氢反应。该方法无需醇盐即可提供芳香族N-杂环，包括吲哚、喹啉、异喹啉和其他 6 元N-杂环，产率良好至极好（对于 48 个实例，产率高达 99%）。

  DOI：

  10.1002/asia.202100861

文献信息

• A Mild and Efficient Palladium-Catalyzed Cyanation of Aryl Mesylates in Water or tBuOH/Water
  作者：Pui Yee Yeung、Chau Ming So、Chak Po Lau、Fuk Yee Kwong

  DOI：10.1002/anie.201005121

  日期：2010.11.15

  Cool and compatible: Aryl mesylates and tosylates underwent palladium‐catalyzed cyanation under mild, aqueous conditions at 65–80 °C (see scheme). In many cases, water could be used as the reaction medium without a cosolvent, and a variety of substituents R, such as keto, aldehyde, ester, free amine, and nitrile groups, remained intact during the transformation. Cy=cyclohexyl, Ms=methanesulfonyl,

  凉爽且相容：芳基甲磺酸酯和甲苯磺酸酯在65-80°C的温和水溶液条件下经历了钯催化的氰化反应（请参见方案）。在许多情况下，可以将水用作没有助溶剂的反应介质，并且在转化过程中，各种取代基R（例如酮，醛，酯，游离胺和腈基）保持完整。Cy =环己基，Ms =甲磺酰基，Ts =对甲苯磺酰基。
• Nickel-Catalyzed Cyanation of Phenol Derivatives with Zn(CN)₂ Involving C–O Bond Cleavage
  作者：Yi Gan、Gaonan Wang、Xin Xie、Yuanhong Liu

  DOI：10.1021/acs.joc.8b02498

  日期：2018.11.16

  An efficient nickel-catalyzed cyanation of aryl sulfonates, fluorosulfonates, and sulfamates with Zn(CN)2 was developed, which provides a facile access to the nitrile products in generally good to excellent yields. The reaction is accomplished by using NiII complex as the precatalyst and DMAP as the additive. The method also displays wide functional group compatibility; for example, keto, methoxy,

  开发了一种有效的镍催化的芳基磺酸盐，氟磺酸盐和氨基磺酸盐与Zn（CN）2的氰化氰化物，该方法可轻松获得腈产品，通常收率良好，收率极佳。该反应是通过使用Ni II配合物作为预催化剂和DMAP作为添加剂来完成的。该方法还显示了广泛的功能组兼容性。例如，在反应过程中，酮，甲氧基，N，N-二甲基氨基，氰基，酯和吡啶基具有良好的耐受性。
• Novel compounds and their use in medicine,as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
  申请人：Debnath Bhunia

  公开号：US20070093476A1

  公开（公告）日：2007-04-26

  The present invention relates to novel compounds of formula (I) and their pharmaceutically acceptable salts, wherein ring “Ar 1 ” represents a monocyclic or polycyclic aromatic or partially saturated aromatic polycyclic, which may optionally contain up to 3 heteroatoms selected from N, S or O. The said monocyclic or polycyclic ring may be unsubstituted or have up to 4 substituents which may be identical or different; m and n independently represents an integer from 0 to 6; A represents O, S or bond; Y is selected from (CH 2 ) p′ (CH 2 ) p B(CH 2 ) q′ (CH 2 ) r B(CH 2 ) p D(CH 2 ) p′ where p, q and r each independently represents an integer from 0 to 6; B and D independently represents S, O, NR 4 or a bond, with a proviso that when B and D represents hereto atom p is not zero; R 4 represents hydrogen, alkyl, alkenyl, —S(O) 2 —R 8 or —C(O)R 8 where R 8 is alkyl, alkoxy; R 5 and R 6 independently represents hydrogen, alkyl, cycloalkyl or alkoxy; R 5 and R 6 together may form 3-8 membered cyclic ring which may optionally contains one or two hereto atoms selected from O, S or N; R 7 represents hydrogen, optionally substituted groups selected form alkyl, cycloalkyl, alkenyl or alkynyl. The present invention also relates to a process for preparation of compounds of formula (I), to pharmaceutical compositions containing compounds of formula (I) and their use in particular as antidiabetic, hypolipidemic, antiobesity and hypocholesterolemic agents.

  本发明涉及公式（I）的新化合物及其药学上可接受的盐，其中环“Ar1”表示单环或多环芳香或部分饱和芳香多环，可选含有最多3个选自N、S或O的杂原子。所述的单环或多环环可以未取代或具有最多4个相同或不同的取代基；m和n分别表示0到6的整数；A表示O、S或键；Y选自（CH2）p′（CH2）pB（CH2）q′（CH2）rB（CH2）pD（CH2）p′，其中p、q和r各自独立地表示0到6的整数；B和D分别表示S、O、NR4或键，条件是当B和D表示杂原子时，p不为零；R4表示氢、烷基、烯基、—S（O）2—R8或—C（O）R8，其中R8为烷基、烷氧基；R5和R6各自独立地表示氢、烷基、环烷基或烷氧基；R5和R6可以一起形成3-8成员环，该环可以选择性地包含选自O、S或N的一个或两个杂原子；R7表示氢、可选地从烷基、环烷基、烯基或炔基中选择的取代基。本发明还涉及公式（I）化合物的制备方法，含有公式（I）化合物的制药组合物以及其作为抗糖尿病、降脂、抗肥胖和降胆固醇药物的应用。
• [EN] NOVEL COMPOUNDS AND THEIR USE AS ANTIDIABETIC AND HYPOLIPIDEMIC AGENTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] NOUVEAUX COMPOSES ET LEUR UTILISATION EN MEDECINE, LEUR PROCEDE DE PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：REDDYS LAB LTD DR

  公开号：WO2005040102A3

  公开（公告）日：2006-03-23
• Nickel-Catalyzed C−O Activation of Phenol Derivatives with Potassium Heteroaryltrifluoroborates
  作者：Gary A. Molander、Floriane Beaumard

  DOI：10.1021/ol101592r

  日期：2010.9.17

  A general method based on nickel-catalyzed C-O activation of various phenol derivatives with potassium (hetero)aryltrifluoroborates has been developed. A large number of heterobiaryls can be easily obtained with yields up to 99% using methanesulfonate cross-coupling partners.